| 12378243 |
Quinoline compounds as inhibitors of KRAS |
Qinda Ye, Matthew S. McCammant, Rocco Policarpo, Artem Shvartsbart, Wenyu Zhu +13 more |
2025-08-05 |
| 12060433 |
CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy |
Horacio G. Nastri, Shaun M. Stewart, Juan Carlos Almagro, Jing Zhou, Rebecca A. Buonpane +9 more |
2024-08-13 |
| 12030883 |
Hetero-tricyclic compounds as inhibitors of KRAS |
Ken Mukai, Haolin Yin, Xiaozhao Wang, Wenqing Yao, Wenyu Zhu |
2024-07-09 |
| 11999740 |
Fused pyrazine derivatives as A2A / A2B inhibitors |
Xiaozhao Wang, Pei Gan, Gia Hoang, Yong Li, Chao Qi +3 more |
2024-06-04 |
| 11999752 |
Vinyl imidazole compounds as inhibitors of KRAS |
Xiaozhao Wang, Alexander Sokolsky, Pei Gan, Rocco Policarpo, Wenqing Yao |
2024-06-04 |
| 11220510 |
Pyrrole tricyclic compounds as A2A / A2B inhibitors |
Xiaozhao Wang, Chunhong He, Taisheng Huang |
2022-01-11 |